INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-18-00196

Acute performance of first- and second-generation transcatheter aortic valves: a quantitative videodensitometric assessment of aortic regurgitation

Yosuke Miyazaki1, MD, PhD; Rodrigo Modolo2, MD; Hiroki Tateishi3, MD, PhD; Patrick W. Serruys4*, MD, PhD

Paravalvular regurgitation (PVR) post transcatheter aortic valve implantation (TAVI) is a feared complication and relates greatly to clinical outcomes – increased late mortality. The development of newer devices with improved technology (enhancement of paravalvular sealing and retrieval/repositioning mechanisms) has decreased the incidence of moderate/severe PVR according to echocardiographic assessment in multiple studies. However, the assessment of PVR with echocardiography using standardised criteria from the Valve Academic Research Consortium (VARC-2) takes into account a wide range of parameters without thorough validation11. Abdelghani M, Soliman OI, Schultz C, Vahanian A, Serruys PW. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. Eur Heart J. 2016;37:2627-44. . PVR assessment during the procedure is challenging, especially in the era of the minimally invasive approach (without general anaesthesia). Videodensitometry assessment of aortic regurgitation (VD-AR) is an objective, quantitative, reproducible, well validated method, performed intraprocedurally with great correlation with magnetic resonance imaging22. Abdel-Wahab M, Abdelghani M, Miyazaki Y, Holy EW, Merten C, Zachow D, Tonino P, Rutten MCM, van de Vosse FN, Morel MA, Onuma Y, Serruys PW, Richardt G, Soliman OI. A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging. JACC Cardiovasc Interv. 2018;11:287-97. ,33. Kapadia SR, Harb SC, Krishnaswamy A. Quantifying Paravalvular Aortic Regurgitation in Transcatheter Aortic Valve Replacement: The Pursuit of Perfection. JACC Cardiovasc Interv. 2018;11:298-300. ,44. Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, Soliman OI, Spitzer E, Perin MA, Onuma Y, Serruys PW, Lemos PA, Brito FS Jr. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016;11:1409-18. . Briefly, it is a software-guided technique in which the density over time is measured in both the aortic root and the left ventricle outflow tract (region with the regurgitated jet) (Panel B, Panel C), and time-density curves are constructed (Panel D). Areas under the curves are calculated and their ratio is the result of the VD-AR assessment, representing the aortic regurgitation severity (Moving image 1). We conducted a retrospective post hoc analysis of post-TAVI aortograms from general clinical practice in an international, multicentre registry in Canada, the Netherlands, Brazil, USA, Germany and Japan. We have examined through an independent academic core laboratory 1,184 post-TAVI aortograms using the software CAAS A-valve 2.0.2 (Pie Medical Imaging BV, Maastricht, the Netherlands). Six different types of valve were implanted and divided into: (i) first-generation (CoreValve® [Medtronic, Minneapolis, MN, USA] and SAPIEN XT [Edwards Lifesciences, Irvine, CA, USA]), and (ii) second-generation (Evolut™ [Medtronic], SAPIEN 3 [Edwards Lifesciences], LOTUS™ [Boston Scientific, Marlborough, MA, USA] and CENTERA [Edwards Lifesciences]). Cumulative frequency curves for both generations were created (Panel A), showing that the second generation has a lower median value of VD-AR (2.0% vs. 9.0%, p<0.001) and a lower incidence of moderate to severe aortic regurgitation (VD-AR >17%)44. Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, Soliman OI, Spitzer E, Perin MA, Onuma Y, Serruys PW, Lemos PA, Brito FS Jr. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016;11:1409-18. (1.9% vs. 22.5%, p<0.001) compared to the first. At first, this finding is easily explained by the device improvement over recent years. However, we also have to consider the growing experience of the operator, advancing on the “learning curve”, and the patient selection, evolving from inoperable to high- and intermediate-risk patients. From these results it might be prematurely concluded that the PVR has been resolved; however, interventions in bicuspid stenotic valves and aortic regurgitation are increasing, thus impacting negatively on the procedure. In conclusion, the improvement of the valves, operators and patient selection play roles in diminishing AR post TAVI. Glimpsing into the near future, the new VD-AR technology has excellent reproducibility, and its online assessment will probably become a useful tool for interventional cardiologists in assessing AR intraprocedurally and in guiding TAVI.

Guest Editor

This paper was guest edited by Alec Vahanian, MD, PhD; Department of Cardiology, Hôpital Bichat-Claude Bernard, and University Paris VII, Paris, France.

Acknowledgement

We thank Jean-Paul Aben for his help and support for the conception of this Interventional Flashlight article.

Conflict of interest statement

The authors have no conflicts of interest to declare. The Guest Editor is a consultant for Edwards Lifesciences.

Supplementary data

Moving image 1. Quantitative aortic regurgitation assessment with videodensitometry.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Quantitative aortic regurgitation assessment with videodensitometry.

Volume 14 Number 4
Jul 20, 2018
Volume 14 Number 4
View full issue


Key metrics

On the same subject

EXPERIMENTAL RESEARCH

10.4244/EIJ-D-17-00595 Jan 19, 2018
Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation
Abdelghani M et al
free

10.4244/EIJV11I10A220 Feb 19, 2016
Accurate procedural assessment of AR – critical for successful TAVI
Kapadia S and Tuzcu ME
free
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved